Improvement in patient- and physician-reported outcomes with apremilast treatment in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial: Analyses by baseline BSA and PASI

Improvement in patient- and physician-reported outcomes with apremilast treatment in patients with mild to moderate plaque psoriasis in the phase 3 ADVANCE trial: Analyses by baseline BSA and PASI Meeting Abstract

publication date

May 1, 2022

webpage

Web of Science

published in

AUSTRALASIAN JOURNAL OF DERMATOLOGY Journal

start page

84

end page

85

volume

63